Xiaoyan Liu1,2, Baojian Wang2, Litao Zhang1, Zhenbo Ma1, Yanlei Wang2, Yishi Wang3, Xiujuan Li1, and Yuanzhong Xie1
1Taian City Central Hospital, Taian, China, 2Shandong First Medical University, Taian, China, 3Philips Healthcare, Beijing, China
Synopsis
Keywords: Breast, CEST & MT, Tumor;Amide proton transfer imaging;
According to the
molecular classification of breast cancer, the clinical therapeutic strategy is
formulated. Currently, the diagnostic value of amide proton transfer (APT)
imaging in breast cancer is still unclear. This study aims to explore the
diagnostic value of APT, DWI, and DCE-MRI in the molecular classification and
prognosis of breast cancer. Our
results showed that there were differences in TTP and BE values between luminal
and non-luminal subtypes of breast cancer. The combination of APT, DWI, and
DCE-MRI had the highest diagnostic efficiency. APT, DWI, and DCE-MRI parameters
were correlated with different prognostic factors of breast cancer.
Introduction
Breast cancer is the
most common malignant tumor with high heterogeneity in women. Its different
histological grades, molecular typing and gene expression make it possible to formulate various
clinical treatment plans. At present, conventional scanning sequences of breast
MRI include T1WI, T2WI, DWI and dynamic contrast enhanced MRI (DCE-MRI), but
their application in breast diseases has certain limitations [1].
Amide proton transfer imaging(APT), as an imaging technique based on chemical
exchange saturation transfer, indirectly reflects the content of free protein
in vivo by detecting the exchange rate of amide protons on polypeptide chains
and hydrogen protons in water and has been increasingly applied to the
characterization of tumors. However, the value of APT in the diagnosis of
breast cancer is still unclear, and there are relatively few reports about the
application of APT in breast diseases. The purpose of this study is to explore
the diagnostic value of APT, DWI and DCE-MRI in molecular classification and
prognosis of breast cancer.Method
This prospective study
was approved by the ethics committee of our hospital, and each patient signed
an informed consent form. 48 cases of breast cancer treated in our hospital
from November 2021 to September 2022 were selected and divided into Luminal
subtype group (n=39) and non-Luminal subtype group (n=9) according to their
molecular classification. T1WI, T2WI, DWI, APT and DCE-MRI scans were performed
for all patients. The ADCb=800 value, asymmetric magnetization
transfer rate with an offset of 3.5ppm[MTRasym (3.5 ppm)], maximum
enhancement(ME), wash-in rate (WIR), time to peak(TTP), Brevity of Enhancement
(BE) of the lesion were measured and compared. Then the diagnostic efficiency
of MRI-related parameters in molecular typing of breast cancer was evaluated by
using the ROC curve. Finally, the correlation between MRI parameters and
different prognostic factors of breast cancer was analyzed by Spearman and
Pearson correlation.Results and discussion
1. comparison of APT,
DWI, and DCE-MRI parameters between luminal and non-luminal breast cancer
patients.
The TTP value and BE
value of non-luminal subtype(Fig.2) were higher than those of luminal type, and the
differences were statistically significant (P=0.017, 0.001, respectively), but
the differences of ME, WIR, MTRasym and ADCb=800 values between the two
groups were not statistically significant (P>0.05) (Table 1, Figure 1). The
enhanced features of DCE-MRI could reflect breast cancer's blood supply and
micro-vessel density. The results of this study suggest that the TTP and BE
values of non-Luminal breast cancer are higher due to the strong proliferation
of tumor cells and more micro-vessels.
2. Analysis of the
diagnostic efficiency of APT, DWI, and DCE-MRI parameters in luminal and non-luminal breast cancer
According to the results of binary logistic
regression analysis, ME, TTP and WIR values in DCE-MRI model were independent predicting
factors in the differentiation of luminal and non-luminal breast cancer (P =
0.030, 0.013, 0.031, respectively), among which TTP value had diagnostic
efficacy, and there was a statistical difference between BE and WIR value (Z=
2.145, P = 0.032).
The diagnostic efficiency of APT + DWI +
DCE-MRI was the highest (Z = 1.351-3.820, P = 0.001-0.009). The AUC of the
combination was 0.973, the sensitivity was 88.9%, and the specificity was
89.7%. The diagnostic efficiency of DCE-MRI had an AUC of 0.89 with a sensitivity
of 77.8%, and a specificity of 74.4% (Fig. 3).
3. Correlation
analysis of APT, DWI, DCE-MRI parameters, and different prognostic factors of
breast cancer
MTRasym
value was positively correlated with T stage and WHO classification; MTRasym
value was associated with PR expression; MTRasym value was positively
correlated with Ki-67 index, while ADC value and ME value were negatively
associated with Ki-67 index. TTP and BE values were correlated with molecular
typing; BE was correlated with ER and PR expression (Fig. 4). The higher the
tumor grade and stage, the stronger the proliferation ability and the more
malignant degree. APT value reflects the protein proliferation ability in
cells, so it is positively correlated with some prognostic factors of breast
cancer.Conclusion
APT, DWI and DCE-MRI
can be used in the differential diagnosis of luminal classification of breast
cancer and the evaluation of the prognosis of breast cancer.Acknowledgements
Youth Science Foundation Project of National Natural Science Foundation of China (grant no. 81903010)References
Wang Ruhua, Zhang Yan,
Cheng Jingliang, Huang Huiyu, Jin Yanan, Li Xiaoming, Zhang YongThree
dimensional amide proton transfer weighted imaging and its combined diffusion
weighted imaging in the differential diagnosis of benign and malignant breast
lesions [J]. Chinese Journal of Radiology, 2022,56 (03): 266-272